| Chassie Collins, | |
|
7608 E 91st St, Tulsa, OK 74133-6014 | |
| (918) 663-0606 | |
| Not Available |
| Full Name | Chassie Collins |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 7608 E 91st St, Tulsa, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013502988 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | CF290 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Chassie Collins, 7608 E 91st St, Tulsa, OK 74133-6014 Ph: (918) 663-0606 | Chassie Collins, 7608 E 91st St, Tulsa, OK 74133-6014 Ph: (918) 663-0606 |
News Archive
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded $2.4 million from the National Institute on Drug Abuse of The National Institutes of Health to expand development of new pain medications with fewer side effects than those currently available...
A review study published today finds that financial incentives -as modest as $5 per week - can increase the amount of exercise people do.
Hot summer weather, stressful situations and intense workouts can produce unpleasant sweaty odors. But what if clothing could cover up these embarrassing smells with a burst of fragrance?
Although PEPFAR has helped to provide "antiretroviral therapy to 2.1 million people with HIV, almost all of whom live in sub-Saharan Africa, and has spent more than US$18 billion on the continent" it has failed to reach "thousands of injecting drug users in PEPFAR countries in Africa, many of whom have HIV," according to the authors of a recent comment in the journal Lancet.
A report published this week in the New England Journal of Medicine shows that the 50 percent of metastatic melanoma patients with a specific genetic mutation benefit from the drug Vemurafenib - increasing median survival from about 6 months to 15.9 months. In patients who responded, the drug stopped cancer progression for a median 6.7 months.
› Verified 3 days ago
Mrs. Katie Elizabeth Aday, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1339 E 55th St, Tulsa, OK 74105 Phone: 918-417-6424 Fax: 918-779-0706 | |
Lisa A Scavezze, MS,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8880 E 105th Ct, Tulsa, OK 74133 Phone: 918-369-8883 | |
Mrs. Katherine Claire Gallegos, M.A, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5842 S Sandusky Ave, Tulsa, OK 74135 Phone: 918-812-8848 | |
Adrienne Lindsey Coleman, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3223 E 31st St, Tulsa, OK 74105 Phone: 918-250-7093 Fax: 918-250-9976 | |
Christina Clark, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6715 E 41st St, Tulsa, OK 74145 Phone: 918-630-3083 | |
Amy Owens, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6740 E 91st St, Tulsa, OK 74133 Phone: 918-852-2119 | |
Anna Coeise Scott, CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 7112 S Mingo Rd, Suite 108, Tulsa, OK 74133 Phone: 918-250-7093 |